Why it was recalled
Discoloration
Product description
Tavaborole Topical solution 5%, 10 mL bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Changodar, Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-102-04.
Lot numbers, UPCs & expiration codes
Lot#: T400819, T400820, Exp 4/30/26; T401969, Exp 9/30/26
Where it was sold
USA Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0016-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Oct 6, 2025
- FDA report date
- Oct 22, 2025
- Quantity
- 13080 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- VIONA PHARMACEUTICALS INC
Original FDA data
Every field from FDA enforcement report D-0016-2026, exactly as published.
Show all FDA fields
- City
- Cranford
- State
- NJ
- Status
- Ongoing
- Country
- United States
- Event ID
- 97756
- Address
- 20 Commerce Dr Ste 340
- Code information
- Lot#: T400819, T400820, Exp 4/30/26; T401969, Exp 9/30/26
- Postal code
- 07016-3617
- Report date
- Oct 22, 2025
- Product type
- Drugs
- Recall number
- D-0016-2026
- Classification
- Class II
- Recalling firm
- VIONA PHARMACEUTICALS INC
- Product quantity
- 13080 bottles
- Reason for recall
- Discoloration
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Tavaborole Topical solution 5%, 10 mL bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Changodar, Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-102-04.
- Distribution pattern
- USA Nationwide
- Recall initiation date
- Oct 6, 2025
- Initial firm notification
- Letter
- Center classification date
- Oct 10, 2025